Abstract

Purpose: To report a novel common-iliac-artery skirt technology (CST) in treating challenge iliac artery aneurysms.Methods: When required healthy landing zone of common iliac artery (CIA) is not available, CST is a strategy to exclude the internal iliac artery (IIA) and prevent IIA reflux without need of embolization. Patients who received endovascular aneurysm repair (EVAR) in our center from 2014 to 2020 were retrospectively screened, and patients treated with CST or with IIA embolization (IIAE) were enrolled.Results: After retrospective screen of 524 EVAR patients, 39 CST patients, 26 IIAE patients, and 7 CST + IIAE patients were enrolled in this study. CST group suggested to have more aged, hyperlipemia, and smoking patients than IIAE group. Two groups had comparable maximal diameter of abdominal aorta (AA), CIA, EIA, but larger diameter of IIA (CST 19.82 ± 2.281 vs. IIAE 27.82 ± 3.401, p = 0.048), and CIA bifurcation (CST 25.01 ± 1.316 vs. IIAE 29.76 ± 2.775, p = 0.087) was found in IIAE group. Anatomy of 79.5% of CST patients and 92.3% of IIAE patients (p = 0.293) was not suitable for potential use of iliac branch device. CST group had significant shorter surgery time (CST 97.42 ± 3.891 vs. IIAE 141.0 ± 8.010, p < 0.001), shorter hospital stay (CST 15.35 ± 0.873 vs. IIAE 19.32 ± 1.067, p = 0.009), lower in-hospital [CST 0% (0/39) vs. IIAE 11.5% (3/26), p = 0.059] and 1-year follow-up stent related MAEs [CST 6.7% (2/30) vs. IIAE 28.6% (6/21), p = 0.052], but comparable mortality and stent related MAEs for all-cohort follow-up analysis comparing to IIAE group. In our study, a lower in-hospital buttock claudication (BC) rate for CST (CST 20.5% vs. IIAE 46.2%, p = 0.053) and a comparable erectile dysfunction (ED) rate (CST 10.3% vs. IIAE 23.1%, p = 0.352) were found between CST and IIAE groups. After 1 year, both groups had about one third relief of BC symptoms [CST 33.3% (4/12) vs. IIAE 30.7% (4/13), p = 1.000]. Subgroup analysis of 14 patents concomitant with IIA aneurysm in CST group and the 7 CST + IIAE patients were carried out, and no difference was found in mortality, stent MAEs, sac dilation, or reintervention rate. Last, illustration of seven typical CST cases was presented.Conclusion: In selected cases, the CST is a safe, feasible-and-effective choose in treating challenge iliac artery aneurysms and preventing IIA endoleak.

Highlights

  • Endovascular aneurysm repair (EVAR) has become the preferred way to treat abdominal aortic aneurysms (AAA) with suitable anatomy and life expectancy [1, 2]

  • Retrospective screen found 524 patients received EVAR in our center from 2014 to 2020, and 39 common-iliac-artery skirt technique (CST) patients, 26 IIA embolization (IIAE) patients, and 7 CST + IIAE patients were enrolled in this study

  • For patients diagnosed with IIAA, concerns may remain on risk of future IIAA enlargement by only covering the orifice of iliac artery (IIA)

Read more

Summary

Introduction

Endovascular aneurysm repair (EVAR) has become the preferred way to treat abdominal aortic aneurysms (AAA) with suitable anatomy and life expectancy [1, 2]. Iliac artery aneurysms (IAAs) are commonly coexisting with AAAs as aorto-iliac aneurysms in about 10–30% of AAA [3, 4], which poses significant clinical and technical challenges during EVAR [5, 6]. Though benefits of preserving IIAs are well-acknowledged and different strategies, devices, such as iliac branch device (IBD), are developed [7]. Such techniques would significantly increase the surgery time and complexity and could be limited by anatomical constraints, technique experience, and availability of grafts. Aneurysmal patients often complicated with cardiovascular diseases that require a feasibleand-effective procedure, particular for ruptured AAA patients [9, 10]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.